Business

The $78 Pill

1 Mins read

Gilead Sciences has set the wholesale price for its new once-a-day HIV/AIDS pill: It’s $28,500 a year. That works out to $78 per pill.

Earlier this year, the Clinton Foundation reported that it has secured generic drugs for delivering combination HIV/AIDS therapy in the developing world for $200 per year. Of course, that requires taking multiple pills several times a day, which makes compliance more difficult.

Gilead Sciences has set the wholesale price for its new once-a-day HIV/AIDS pill: It’s $28,500 a year. That works out to $78 per pill.

Earlier this year, the Clinton Foundation reported that it has secured generic drugs for delivering combination HIV/AIDS therapy in the developing world for $200 per year. Of course, that requires taking multiple pills several times a day, which makes compliance more difficult.

Gilead’s four-drug combo pill, taken just once a day, clearly is an innovation. But is it really 140 times more valuable than a generic approach? Perhaps the U.S. health care system should sign up for help from the Clinton Foundation.

Related posts
BusinessHospital Administration

Attracting New Patients to Your Medical Practice

3 Mins read
Whether you’ve just opened your medical clinic or you’ve been in business for years, trying to persuade individuals to entrust you with…
BusinessFinance

Top Money-Saving Tips for Medical Laboratories

3 Mins read
Even with funding sources like loans, government grants, and donations, managing a laboratory isn’t cheap. From finding an ideal commercial property and…
BusinessGlobal HealthcareTechnology

Improving Healthcare Services And Management Through Tech Integration

3 Mins read
  There is no denying that technology is rapidly transforming every industry in the world, including modern healthcare services in developed economies…